UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 26, 2009
Vision-Sciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware | |
000-20970 | |
13-3430173 |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| |
40 Ramland Road South
Orangeburg, NY | |
10962 | |
| | (Address of principal executive offices) | | (Zip Code) | |
Registrant's telephone number, including area code: (845) 365-0600
________________________________________________________________________________
(Former name or former address, if changed since last report)
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| | [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.
(d) On June 26, 2009, the Board of Directors of the Registrant elected Mr. John J. Rydzewski to serve on the Registrant's Board of Directors and the Audit Committee of the Board of Directors. Information regarding Mr. Rydzewski and his position on the Board of Directors is contained in the press release attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 8.01. Other Events.
On June 29, 2009 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Exhibit 99.1. Press release dated June 29, 2009
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | Vision-Sciences, Inc.
(Registrant)
|
June 29, 2009
(Date) | | /s/ KATHERINE L. WOLF
Katherine L. Wolf
CFO & EVP Corporate Development |
